HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richlocaine in combined therapy of periodontitis.

Abstract
The results of combined therapy of chronic moderate generalized periodontitis can be improved by adding richlocaine to protocols of drug therapy: the drug reduces the time of treatment, prolongs remission, decreases the number of relapses, and stabilizes pathological processes in periodontal tissues.
AuthorsV I Popkov, A V Zadorozhnyi, P A Galenko-Yaroshevskii
JournalBulletin of experimental biology and medicine (Bull Exp Biol Med) Vol. 136 Issue 4 Pg. 372-4 (Oct 2003) ISSN: 0007-4888 [Print] United States
PMID14714086 (Publication Type: Clinical Trial, Comparative Study, Journal Article)
Chemical References
  • Analgesics
  • Anti-Bacterial Agents
  • Piperidines
  • richlocaine
Topics
  • Adult
  • Aged
  • Analgesics (therapeutic use)
  • Anti-Bacterial Agents (therapeutic use)
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Periodontitis (diagnostic imaging, drug therapy, pathology, prevention & control)
  • Piperidines (therapeutic use)
  • Radiography
  • Secondary Prevention

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: